Treatment delayed tumor growth and reduced metastasis in correlation with viral propagation and F4/80+, CD4+, and CD8+ immune cell infiltration, with reduced toxicity compared to wild type coxsackievirus B3 (94). The gene discussed is CD8A; the disease is neoplasm.